Navigation Links
Vasogen Announces Third Quarter 2007 Results
Date:10/9/2007

capital on acceptable terms to pursue the development of Celacade, and the feasibility of additional trials. You should not place undue reliance on our forward-looking statements which are subject to a multitude of risks and uncertainties that could cause actual results, future circumstances or events to differ materially from those projected. These risks include, but are not limited to, the outcome of further ongoing analysis of the ACCLAIM trial results, the requirement or election to conduct additional clinical trials and the size and design of any such trials, delays or setbacks in the regulatory approval process, difficulties in the maintenance of existing regulatory approvals, securing and maintaining corporate alliances, the need for additional capital and the effect of capital market conditions and other factors on capital availability, the potential dilutive effects of any financing, risks associated with the outcomes of our preclinical and clinical research and development programs, the adequacy, timing, and results of our clinical trials, competition, market acceptance of our products, the availability of government and insurance reimbursements for our products, the strength of intellectual property, reliance on partners, subcontractors, and key personnel, losses due to fluctuations in the U.S.-Canadian exchange rate, and other risks detailed from time to time in our public disclosure documents or other filings with the Canadian and U.S. securities commissions or other securities regulatory bodies. Additional risks and uncertainties relating to our Company and our business can be found in the "Risk Factors" section of our Annual Information Form and Form 20-F for the year ended November 30, 2006, as well as in our later public filings. The forward-looking statements are made as of the date hereof, and we disclaim any intention and have no obligation or responsibility, except as required by law, to update or revise any forward-looking statements, whether a
'/>"/>
SOURCE Vasogen Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 18, 2014 Array Architects is proud ... expertise to the nation's hospitals and health systems. It ... those dedicating their careers to the advancement of both ... in her respective field, Laura Silvoy has been chosen ... 2014 Winter Simulation Conference. , Laura will present ...
(Date:11/18/2014)... , Nov. 18, 2014  Asterias Biotherapeutics, Inc. ... the emerging field of regenerative medicine, today announced ... progenitor cells) for complete cervical spinal cord injury ... "Top Advanced Therapies Projects to Watch" by Elsevier ... receive this significant industry honor, which represents independent ...
(Date:11/18/2014)... 2014  Novira Therapeutics, Inc., a privately held biopharmaceutical ... hepatitis B virus (HBV) infection, today announced that ... Scientific Advisory Board (SAB).  "We are ... Christian S. Schade , Chief Executive Officer of Novira.  ... will be invaluable to Novira as our lead core ...
(Date:11/17/2014)... , Nov. 17, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today the formation of a ... guidance to the Company as it advances the ... for the treatment of cutaneous T-cell lymphoma (CTCL), ...
Breaking Biology Technology:Array Healthcare Simulation Expert Slated to Speak at Winter Simulation Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 3Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6
... to Detail Latest Cardiac Surgery Technology to be Held ... January 26th at 6:30 p.m. ... leading,medical technology companies will host the first annual After Hours ... aboard the yacht,"Princess Lady." The invitation-only event, immediately preceding the,largest ...
... Jan. 15 In response to the,Federal Drug ... are safe for human consumption, Smithfield Foods, Inc.,(NYSE: ... company is not planning,to produce meat products from ... relatively new. As thoughtful leaders in our industry,we ...
... BioSpecifics,Technologies Corp. (Pink Sheets: BSTC.PK) today announced ... stock, in a private placement,offering to an investment ... share for,aggregate proceeds to the Company of $2,100,000., ... Corp. is a biopharmaceutical company that has,developed and ...
Cached Biology Technology:Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 2Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 3Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 4
(Date:11/4/2014)... – (Nov. 4, 2014) – A majority of Madagascar,s ... that could have serious consequences for the rainforests they ... shows the positive impacts lemurs can have on rainforest ... their disappearance could have on the region,s rich biodiversity. ... have fruits eaten by lemurs. Lemurs in turn ...
(Date:11/3/2014)... report that low birth weight and preterm birth are ... in adulthood. Findings published in the American College of ... indicate that low birth weight and pre-term babies were ... OA as adults. , According to the ACR, ... diagnosed with clinical OA. Symptoms of OA range from ...
(Date:10/31/2014)... HMS Center for Biomedical Informatics (CBMI) has received two ... infusion of support will enable the center to continue ... and the other involving new approaches to precision medicine. ... National Human Genome Research Institute and the National Institute ... Center for Excellence in Genomic Science, or CEGS. , ...
Breaking Biology News(10 mins):Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3Preterm, low birth-weight babies may need new hips in adulthood 2Transforming 'big data' into knowledge 2Transforming 'big data' into knowledge 3
... the first time, scientists have mapped the genome--the genetic code--of ... to maintain the genetic diversity of captive and wild orangutans. ... used to help improve our understanding of the evolution of ... Science Foundation, the orangutan study appears in the Jan. 27 ...
... What separates humans from Chimpanzees? Is it ... and behavior capabilities? To Professor Wallace Arthur it is ... book Evolution: A Developmental Approach sits between the ... approach to provide a complete view on the evolutionary ...
... release is available in German . , ... jointly develop new battery materials at KIT in the ... was signed by Professor Eberhard Umbach, President of KIT, ... Executive Directors of BASF SE, Ludwigshafen. The BELLA (Batteries ...
Cached Biology News:Scientists determine what makes an orangutan an orangutan 2Scientists determine what makes an orangutan an orangutan 3BASF and Karlsruhe Institute of Technology develop tomorrow's battery materials 2
...
Anti-MMP-7, aminoterminal end active enzyme; rabbit host...
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
Mouse monoclonal [7C6] to Bcr-abl ( Abpromise for all tested applications). SwissProtID: P11274...
Biology Products: